Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

The study concluded that certain hair growth measurements are good indicators of baldness severity and provide a more accurate assessment than subjective grading.

The micrometer caliper is a reliable tool for measuring hair diameter for FUE surgery.

New method measures skin cell turnover quickly and effectively, showing turnover slows with age and responds more to treatments in older skin.

Both EQ-5D-5L and SF-6DV2 are valid for measuring health but can't be used interchangeably.

Psychological and social responses to scars can indicate mental health risks.

The study created a 27-item measure to assess the impact of skin diseases.

Psoriasis patients did not show more brain atrophy or small vessel disease than controls, but longer psoriasis duration was linked to more brain atrophy.

A new method accurately measures cyclic AMP levels in small skin and hair samples.

Hair loss significantly affects quality of life, especially for women, in Pakistan.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Standardized data is essential for diagnosing scalp and hair conditions in males.

A man has a common skin condition called seborrheic dermatitis, treated with special shampoos and sometimes medication.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

The Progressive Loss Risk Scale is a system that shows the long-term risks of hair restoration surgery, which can change based on factors like age and transplant area.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

A new tool helps better assess and treat hair loss in Chinese men.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

Healthier hair and scalp improve mental wellbeing.

SII is a useful and affordable tool to assess and monitor alopecia areata.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Hair mass index is a precise way to measure hair loss in chemotherapy patients.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.